Kevin Balthaser

Kevin Balthaser

Chief Financial OfficeratAclaris Therapeutics· In proxies 2023–2025

Pay in FY2024Aclaris Therapeutics stock +136.2% the same year

Kevin Balthaser was paid $1.1M in FY2024 (Dec). Aclaris Therapeutics stock rose 136.2% that year.

Pay$100 in the stock at the end of FY23 → $236
Pay is from the Summary Compensation Table of each Aclaris Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aclaris TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role -74%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?